Did you know that about 35% of patients already show signs of #lupusnephritis by the time that they are diagnosed with systemic #lupus erythematosus (Izmirly et al., 2017)? Early detection and management are critical for those affected by these diseases. Learn more about how to have conversations with your health care provider here: https://lnkd.in/egCmCqZM
Aurinia Pharmaceuticals Inc.
Biotechnology Research
Edmonton, Alberta 26,072 followers
About us
We pursue promising science to address some of the toughest challenges in autoimmune disease. Community guidelines: 1. By posting to our social media channels, or otherwise responding or commenting on our posts, you are agreeing to abide by these guidelines, which apply in addition to any terms and conditions or other notices or disclaimers that we may apply, or that may be applied by the host of the social media platform itself. 2. Unless posts are from an official Aurinia social media handle, none of the posts or comments are posts made by us, but from members of the public. We take no responsibility for comments or posts made by third parties on our channels, and the content of those comments or posts (including any opinions or statements) may not reflect our views, and are the responsibility of the individual posting them. 3. We may discuss medical and health-related topics on our social media feeds. The content we post, and any associated content shared by other users, should not be taken as medical advice. We ask that you refrain from soliciting or posting medical advice on this feed. For advice and information related to your health, please seek advice from your doctor or other healthcare professional. 4. Aurinia reserves the right to remove any content or comments that violate these guidelines or are otherwise deemed inappropriate. We may block or ban users who repeatedly violate these guidelines or engage in disruptive behavior. To learn more, visit: https://www.auriniapharma.com/aurinia-community-guidelines US-NA-2300266 08/23
- Website
-
http://www.auriniapharma.com/
External link for Aurinia Pharmaceuticals Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Edmonton, Alberta
- Type
- Public Company
- Founded
- 2013
- Specialties
- Biotechnology, Immunology, Lupus Nephritis, Drug Development, autoimmune, and Nephrology
Locations
-
Primary
Get directions
Edmonton, Alberta, CA
-
Get directions
#201, 17904 - 105 Avenue
Edmonton (West Northwest Industrial / Winterburn), AB T5S 2H5, CA
-
Get directions
77 Upper Rock Circle
Suite 700
Rockville, MD 20850 , US
Employees at Aurinia Pharmaceuticals Inc.
Updates
-
We’re pleased to announce our upcoming presence at the Leerink Partners Therapeutics Forum, July 9-10 and the H.C. Wainwright & Co., LLC Virtual Kidney Conference, July 15. Learn more: https://lnkd.in/gaUpAbny
-
Join us for our next virtual Legislative Roundtable on Monday, June 24th at 5:30 pm ET. We are excited to be joined by Representative Brian Cunningham, Dr. Ellen Ginzler and our patient opinion leader Tiffany, as we continue to build awareness around lupus nephritis (LN) and its impact on patients. The discussion will also highlight meaningful policy initiatives that can help impact long-term kidney health for people living with #lupus. To learn more or register: https://lnkd.in/gHK_QHj9
-
-
Today, we commemorate #Juneteenth, a pivotal moment in American history marking the end of slavery. At Aurinia, we honor this day by reaffirming our commitment to equality, diversity, and inclusion within our organization and within the communities we serve to ensure quality healthcare for all.
-
-
As we reflect on #LupusAwarenessMonth, we would like to spotlight the impactful collaborations and educational initiatives we've undertaken with the #lupus and #lupusnephritis communities. Explore some highlights from Aurinia’s efforts throughout the month, contributing to the goal of advancing health equity and accessibility.
-
Last month we joined the NATIONAL MINORITY HEALTH ASSOCIATION's Lupus Call to Action Day event to drive timely access to care and ways to improve health equity among people with #lupus and #lupusnephritis. Grammy-award-winning artist Toni Braxton discussed the importance of maintaining a consistent relationship with your doctor to prioritize your kidney health by staying on top of routine visits and screenings. This #CallYourDoctorDay, we encourage people living with #lupus and #lupusnephritis to take a proactive step in their health management by checking in with their doctor to monitor their kidney health. Hear more from Toni here: http://bit.ly/3RdqHlq
-
-
Did you know that men with LN are five times more likely to progress to end-stage renal disease compared to women (Ramírez Sepúlveda et al., 2019)? As we honor #MensHealthMonth, we're spotlighting the crucial need for better care and support for men living with #lupus and #lupusnephritis. Learn more here: https://lnkd.in/egCmCqZM
-
We’re looking forward to presenting at the EULAR - European Alliance of Associations for Rheumatology 2024 meeting, where we’ll share new data on #lupusnephritis management. Read more: https://lnkd.in/gCesBTzz
-
-
Happy #PrideMonth! At Aurinia, we're committed to supporting the LGBTQIA+ community by fostering an equal and welcoming environment for all. Today and every day, we celebrate the diversity and inclusivity that strengthens our communities.
-
-
We’re pleased to announce our upcoming presence at the Jefferies Investor conference, June 5-6. Learn more: https://lnkd.in/gfmqnm9y
Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
auriniapharma.com